152 related articles for article (PubMed ID: 3002596)
1. Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors.
Tiffany P; Morse MJ; Bosl G; Vaughan ED; Sogani PC; Herr HW; Whitmore WF
Cancer; 1986 Mar; 57(5):978-83. PubMed ID: 3002596
[TBL] [Abstract][Full Text] [Related]
2. Radical retroperitoneal node dissection after chemotherapy for testicular tumours.
Williams SN; Jenkins BJ; Baithun SI; Oliver RT; Blandy JP
Br J Urol; 1989 Jun; 63(6):641-3. PubMed ID: 2546643
[TBL] [Abstract][Full Text] [Related]
3. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
Herr HW; Toner GC; Geller NL; Bosl GJ
Eur Urol; 1991; 19(1):1-5. PubMed ID: 1848821
[TBL] [Abstract][Full Text] [Related]
4. Postchemotherapy surgery in nonseminomatous testicular tumors.
Hornák M; Ondrus D; Matoska J; Cársky S
Eur Urol; 1996; 29(3):325-30. PubMed ID: 8740018
[TBL] [Abstract][Full Text] [Related]
5. Retroperitoneal lymph node dissection after chemotherapy.
Winter C; Raman JD; Sheinfeld J; Albers P
BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
[TBL] [Abstract][Full Text] [Related]
6. Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma.
Clevenger JA; Foster RS; Ulbright TM
Mod Pathol; 2009 Oct; 22(10):1361-6. PubMed ID: 19633644
[TBL] [Abstract][Full Text] [Related]
7. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
[TBL] [Abstract][Full Text] [Related]
8. [Temporary transsection of the inferior vena cava for complete removal of a retroperitoneal metastatic testicular tumor].
Kumada K; Okada Y; Okada K; Morikawa S; Yoshida O
Chirurg; 1988 Oct; 59(10):676-8. PubMed ID: 2848663
[No Abstract] [Full Text] [Related]
9. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
10. Management of post-chemotherapy extra-retroperitoneal residual masses.
Carver BS; Sheinfeld J
World J Urol; 2009 Aug; 27(4):489-92. PubMed ID: 19373472
[TBL] [Abstract][Full Text] [Related]
11. [Retroperitoneal lymph node dissection for patients with advanced testicular tumor].
Takasaki N; Ueda H; Isurugi K
Hinyokika Kiyo; 1994 Oct; 40(10):957-61. PubMed ID: 7992714
[TBL] [Abstract][Full Text] [Related]
12. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
[TBL] [Abstract][Full Text] [Related]
13. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
[TBL] [Abstract][Full Text] [Related]
14. ["Growing teratoma syndrome": an unrecognized complication of treated germ cell tumors of the testis].
Ghaouti M; Roquet L; Fazzalari L; Sibert L; Sabourin JC
Ann Pathol; 2013 Dec; 33(6):402-5. PubMed ID: 24331722
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update.
Gupta A; Feifer AH; Gotto GT; Kraus D; Motzer R; Bosl GJ; Bajorin D; Feldman DR; Carver B; Sheinfeld J
Urology; 2011 Mar; 77(3):655-9. PubMed ID: 21377010
[TBL] [Abstract][Full Text] [Related]
16. The importance of one-stage median sternotomy and retroperitoneal node dissection in disseminated testicular cancer.
Mandelbaum I; Yaw PB; Einhorn LH; Williams SD; Rowland RG; Donohue JP
Ann Thorac Surg; 1983 Nov; 36(5):524-8. PubMed ID: 6195980
[TBL] [Abstract][Full Text] [Related]
17. Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis.
Nitta S; Kawai K; Kimura T; Kandori S; Kawahara T; Kojima T; Nishiyama H
Int J Urol; 2021 Aug; 28(8):840-847. PubMed ID: 34085325
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.
Brenner PC; Herr HW; Morse MJ; Sheinfeld J; Aprikian A; Bosl GJ; Motzer RJ; Bajorin DF; Schantz S; Fair WR; Burt M
J Clin Oncol; 1996 Jun; 14(6):1765-9. PubMed ID: 8656244
[TBL] [Abstract][Full Text] [Related]
19. The extent of surgery after chemotherapy for advanced germ cell tumors.
Freiha FS; Shortliffe LD; Rouse RV; Mark JB; Hannigan JF; Aston D; Spaulding JT; Williams RD; Torti FM
J Urol; 1984 Nov; 132(5):915-7. PubMed ID: 6208386
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.
Masterson TA; Carver BS; Shayegan B; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2012 May; 79(5):1079-84. PubMed ID: 22446341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
